The researchers found that patients taking GLP-1 RAs had a significantly reduced incidence of revision FESS versus the non-GLP-1 RA group at one-year (risk ratio [RR], 0.64) and five-year follow-up ...

An 18-year-old’s long-standing snoring and nasal congestion were brushed off as allergies, until the doctor revealed a nasal ...

A new study found that glucagon-like peptide-1 receptor agonists (GLP-1RAs), which include popular weight loss drugs like ...

Ondine’s Steriwave Expands into ENT Surgery in Spain Ondine Biomedical Inc, a leader in light-activated antimicrobial therapies, has expanded into Spain.  Its Steriwave® nasal photodisinfection ...

From Dupixent to Tezspire and verekitug, explore emerging sinusitis treatments and the race to improve chronic rhinosinusitis ...

The decision to proceed with surgery should be based on a thorough evaluation, objective evidence of disease, and a clear ...

Singer and voice-over actor Eric Hollaway struggled since childhood with severe allergies and then nasal polyps, which left ...

A new study published in Otolaryngology–Head and Neck Surgery reveals that glucagon-like peptide-1 receptor agonists ...

What starts as a minor inconvenience can snowball into chronic sinusitis, recurrent infections, and even more serious ENT ...

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

Findings showed treatment with tezepelumab significantly reduced the size of nasal polyps and nasal congestion compared with placebo. The Food and Drug Administration (FDA) has approved Tezspire ® ...

(Reuters) -The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus disease, the drugmakers said on Friday. The approval expands the use ...